Climb Bio, Inc. Common Stock (NASDAQ: CLYM) last traded at $10.83, down 1.55% on the session. The quote above updates while this page is open; the figures below are drawn from Climb Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Climb Bio, Inc. Common Stock trades on NASDAQ under the ticker CLYM. Its market capitalisation is $622.03 million.
Valuation measures for Climb Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $622.03M |
|---|---|
| Enterprise value | $584.67M |
| Price / book | 2.60 |
| Beta | 1.66 |
Trailing-twelve-month figures tagged in Climb Bio, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$57.62M |
| EPS (TTM) | -$0.820 |
|---|
| Return on equity | -24.06% |
|---|
| Cash | $44.11M |
|---|
Range and volume for CLYM over the past 52 weeks.
| 52-week high | $18.33 |
|---|---|
| 52-week low | $1.64 |
| Volume | 911.6K |
| Average volume | 1.36M |
| Previous close | $11.00 |
Invest a chosen dollar amount in Climb Bio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CLYM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.